Back to mobile site

Goldman Sachs Removes Allergen (AGN) from Conviction Buy List

March 3, 2011 6:47 AM EST Send to a Friend
Goldman Sachs removed Allergen (NYSE: AGN) from its Conviction Buy List, replacing it with Hologic (Nasdaq: HOLX) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login